Replies to post #385 on CytoSorbents Corporation (CTSO)

[petergriffin]

The PR back in mid Nov:

"European Sepsis Trial -- Including our Sepsis Pilot Study, we have enrolled a total of 39 patients in our trial, including 17 patients under a new protocol designed to improve data quality and enhance recruitment. To complete our trial, we are looking to enroll an additional 40 patients, but if needed, can go up to 60."

39+40=79. Call me a liar for sake of difference of 1. I believe there are other documents and references in respect of recruiting 80.